Arcturus Therapeutics Holdings (ARCT) Financials

ARCT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 429.4 million 150.9 million
2023-09-30 457.7 million 177.6 million
2023-06-30 430.6 million 145.5 million
2023-03-31 470.9 million 141.6 million

ARCT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.4 million 8.8 million
2023-09-30 -33.4 million 9.3 million
2023-06-30 50.5 million 8.4 million
2023-03-31 -36.6 million 8.2 million

ARCT Net Income

No data available :(

ARCT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 347.0 million - 30.2 million
2023-09-30 311.9 million - 27.0 million
2023-06-30 323.5 million - 32.2 million
2023-03-31 327.9 million - 29.2 million

ARCT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 26.6 million
2023-09-30 26.6 million
2023-06-30 26.6 million
2023-03-31 27.1 million

ARCT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 837076 26.8 million 12.5 million 815000
2023-09-30 981000 51.1 million 13.4 million -
2023-06-30 354000 52.7 million 13.2 million -
2023-03-31 691000 51.8 million 13.8 million -

ARCT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 28.2 million 815000
2023-09-30 43.4 million 800000
2023-06-30 9.6 million 52.7 million
2023-03-31 79.7 million 51.8 million

ARCT

Price: $26.55

52 week price:
17.52
43.81

Earnings Per Share: -1.12 USD

P/E Ratio: 10.54

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 359653

Ebitda: -2.9 million

Market Capitalization: 860.5 million

Average Dividend Frequency: 1

Links: